Cargando…

Prognostic significance of thromboembolism in multiple myeloma: a systematic review and meta-analysis

BACKGROUND: This study sought to investigate the clinical characteristics and prognosis of thromboembolism in multiple myeloma (MM). METHODS: The PubMed, Embase, Web of Science, Wanfang, and China National Knowledge Infrastructure (CNKI) databases were systematically searched to retrieve relevant ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	An, Na, Zhang, Liang, Gu, Lei, Tang, Tingting, Zhou, Hui, Tian, Guoyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080304/ https://www.ncbi.nlm.nih.gov/pubmed/37033347 http://dx.doi.org/10.21037/tcr-23-285

Ejemplares similares

Prognostic significance of FSCN family in multiple myeloma
por: Deng, Cong, et al.
Publicado: (2021)

MiRNAs with prognostic significance in multiple myeloma: A systemic review and meta-analysis
por: Xu, Peipei, et al.
Publicado: (2019)

Clinicopathological significance of the p16 hypermethylation in multiple myeloma, a systematic review and meta-analysis
por: Yu, Huiqing, et al.
Publicado: (2017)

Prognostic significance of esterase gene expression in multiple myeloma
por: Kumari, Romika, et al.
Publicado: (2021)

Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy
por: Chakraborty, Rajshekhar, et al.
Publicado: (2021)

Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma
por: Binder, M, et al.
Publicado: (2016)

Venous thromboembolism in multiple myeloma is associated with increased mortality
por: Schoen, Martin W., et al.
Publicado: (2020)

Incidence of Arrhythmias and Their Prognostic Value in Patients With Multiple Myeloma
por: Li, Yongxin, et al.
Publicado: (2021)

Prediction and prognostic significance of BCAR3 expression in patients with multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2018)

The Prognostic Role of Cyclin D1 in Multiple Myeloma: A Systematic Review and Meta-Analysis
por: Jiang, Yuwen, et al.
Publicado: (2022)

Rivaroxaban for cancer-associated venous thromboembolism: A systematic review and meta-analysis protocol
por: Liang, Bo, et al.
Publicado: (2019)

The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patients
por: Yao, Weiqin, et al.
Publicado: (2023)

Validation of Risk-Adapted Venous Thromboembolism Prediction in Multiple Myeloma Patients
por: Barrett, Aisling, et al.
Publicado: (2021)

Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma
por: Sanfilippo, Kristen M., et al.
Publicado: (2022)

Nursing management of treatment-related venous thromboembolism in patients with multiple myeloma
por: Yang, Bianhong, et al.
Publicado: (2023)

P977: THE VENOUS THROMBOEMBOLISM RISK ASSESMENT MODELS IN MULTIPLE MYELOMA
por: Alp Kirkizlar, Tugcan, et al.
Publicado: (2023)

Prognostic Significance of the Stage at Which an MRD-Negative Status Is Achieved for Patients With Multiple Myeloma Who Received ASCT
por: Sun, Qian, et al.
Publicado: (2022)

Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance
por: Baysal, Mehmet, et al.
Publicado: (2020)

A diagnostic approach to detect cytogenetic heterogeneity and its prognostic significance in multiple myeloma
por: Kalal, Akanksha A., et al.
Publicado: (2023)

Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis
por: Zhang, Xinwen, et al.
Publicado: (2021)

Impact of Time-Varying Treatment Exposures on the Risk of Venous Thromboembolism in Multiple Myeloma
por: Brown, Joshua D., et al.
Publicado: (2016)

Efficacy and Safety of Panobinostat in Relapsed or/and Refractory Multiple Myeloma: Meta Analyses of Clinical Trials and Systematic Review
por: Liu, Jing-di, et al.
Publicado: (2016)

Is RDW a clinically relevant prognostic factor for newly diagnosed multiple myeloma? A systematic review and meta-analysis
por: Chen, Xiaomin, et al.
Publicado: (2022)

Prognostic Significance of the Dynamic Change of Programmed Death-ligand 1 Expression in Patients with Multiple Myeloma
por: Guan, Jian, et al.
Publicado: (2019)

Prognostic significance of dysregulation of shelterin complex and its correlation with telomere length and cytogenetics in multiple myeloma
por: Kalal, Akanksha A., et al.
Publicado: (2023)

Cytogenetic Abnormalities in Multiple Myeloma: Incidence, Prognostic Significance, and Geographic Heterogeneity in Indian and Western Populations
por: Kadam Amare, Pratibha, et al.
Publicado: (2023)

Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017
por: Yin, Xuejiao, et al.
Publicado: (2018)

Prognostic Significance of Initial Serum Albumin and 24 Hour Daily Protein Excretion before Treatment in Multiple Myeloma
por: Chen, Jia-Hong, et al.
Publicado: (2015)

Huanglian Jiedu Decoction for treatment of multiple myeloma: A protocol for a systematic review and meta-analysis
por: An, Na, et al.
Publicado: (2020)

Prognostic factors and classification in multiple myeloma.
por: San Miguel, J. F., et al.
Publicado: (1989)

A prognostic index for multiple myeloma.
por: Grignani, G., et al.
Publicado: (1996)

The Evolution of Prognostic Factors in Multiple Myeloma
por: Hanbali, Amr, et al.
Publicado: (2017)

Immunological Prognostic Factors in Multiple Myeloma
por: Bębnowska, Dominika, et al.
Publicado: (2021)

Prognostic significance of preoperative prognostic nutritional index in ovarian cancer: A systematic review and meta-analysis
por: Dai, Yan, et al.
Publicado: (2020)

Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis
por: Wei, Bing, et al.
Publicado: (2016)

Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
por: Zhang, Yue, et al.
Publicado: (2019)

Lenalidomide and the risk of serious infection in patients with multiple myeloma: a systematic review and meta-analysis
por: Ying, Li, et al.
Publicado: (2017)

PB2090: SYSTEMATIC LITERATURE REVIEW OF PROGNOSTIC FACTORS FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
por: Kumar, Shaji, et al.
Publicado: (2023)

P969: COMPARISON OF VENOUS THROMBOEMBOLISM INCIDENCE IN MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE-BASED REGIMENS WITH RIVAROXABAN OR ASPIRIN THROMBOPROPHYLAXIS
por: Wang, Y., et al.
Publicado: (2022)

The prognostic significance of prognostic nutritional index in gastrointestinal stromal tumors: A systematic review and meta-analysis
por: Li, Zhenjie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5m5c866pbh8d4fhkfoulfekd70